| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00068-017-0833-3 |
| P698 | PubMed publication ID | 28918481 |
| P50 | author | Marta Madurska | Q89004487 |
| Jonathan Morrison | Q43092400 | ||
| Todd E Rasmussen | Q56395891 | ||
| P2093 | author name string | J O Jansen | |
| K A Sachse | |||
| P2860 | cites work | Tranexamic acid in trauma: how should we use it? | Q85542937 |
| Influence of resuscitation fluids, fresh frozen plasma and antifibrinolytics on fibrinolysis in a thrombelastography-based, in-vitro, whole-blood model | Q86109739 | ||
| Consistency of thromboelastometry analysis under scrutiny: results of a systematic evaluation within and between analysers | Q87192915 | ||
| Antifibrinolytic drugs for acute traumatic injury | Q24188000 | ||
| Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion | Q24235742 | ||
| A cell-based model of hemostasis | Q28204461 | ||
| Macromolecular specificity determinants on thrombin for fibrinogen and thrombomodulin | Q28252588 | ||
| Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial | Q28285511 | ||
| Effect of tranexamic acid on mortality in patients with traumatic bleeding: prespecified analysis of data from randomised controlled trial | Q28727918 | ||
| Mechanism of action of tranexamic acid in bleeding trauma patients: an exploratory analysis of data from the CRASH-2 trial | Q30877676 | ||
| Criteria for empiric treatment of hyperfibrinolysis after trauma | Q33402032 | ||
| Tranexamic acid leads to paradoxical coagulation changes during cardiac surgery: a pilot rotational thromboelastometry study | Q33442625 | ||
| Tranexamic acid for treatment and prophylaxis of bleeding and hyperfibrinolysis | Q33676496 | ||
| Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate | Q33919203 | ||
| Remodeling the blood coagulation cascade | Q34294608 | ||
| Tranexamic acid in trauma: how should we use it? | Q34345917 | ||
| Coagulation 2006: a modern view of hemostasis. | Q34606940 | ||
| Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: the spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy | Q35207771 | ||
| Thrombelastography and biomarker profiles in acute coagulopathy of trauma: a prospective study. | Q35540641 | ||
| Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. | Q35559379 | ||
| Functional definition and characterization of acute traumatic coagulopathy | Q35571219 | ||
| Fibrinolysis shutdown phenotype masks changes in rodent coagulation in tissue injury versus hemorrhagic shock | Q35822899 | ||
| Disseminated intravascular coagulation or acute coagulopathy of trauma shock early after trauma? An observational study. | Q36073044 | ||
| Thrombelastography/thromboelastometry. | Q36077355 | ||
| CRASH-3 - tranexamic acid for the treatment of significant traumatic brain injury: study protocol for an international randomized, double-blind, placebo-controlled trial | Q36347953 | ||
| Reaction pattern to three stresses--electroplexy, surgery, and myocardial infarction--of fibrinolysis and plasma fibrinogen | Q36550406 | ||
| Acute Fibrinolysis Shutdown after Injury Occurs Frequently and Increases Mortality: A Multicenter Evaluation of 2,540 Severely Injured Patients | Q36807586 | ||
| Emerging role of anticoagulants and fibrinolytics in the treatment of acute respiratory distress syndrome | Q36835719 | ||
| Thrombelastography and tromboelastometry in assessing coagulopathy in trauma. | Q37379818 | ||
| Early evaluation of acute traumatic coagulopathy by thrombelastography | Q37518734 | ||
| Activated Protein C Drives the Hyperfibrinolysis of Acute Traumatic Coagulopathy. | Q37600822 | ||
| Seizures after cardiac surgery | Q37805161 | ||
| Hemoglobin-based oxygen carriers promote systemic hyperfibrinolysis that is both dependent and independent of plasmin | Q38732501 | ||
| Fibrinolysis in Trauma: "Myth," "Reality," or "Something in Between". | Q38755236 | ||
| Viscoelastic Tissue Plasminogen Activator Challenge Predicts Massive Transfusion in 15 Minutes | Q38776292 | ||
| Freeze-dried plasma enhances clot formation and inhibits fibrinolysis in the presence of tissue plasminogen activator similar to pooled liquid plasma | Q38788377 | ||
| Diagnosis and Treatment of Hyperfibrinolysis in Trauma (A European Perspective). | Q39144483 | ||
| Tranexamic Acid Use in Prehospital Uncontrolled Hemorrhage | Q39364102 | ||
| The importance of early treatment with tranexamic acid in bleeding trauma patients: An exploratory analysis of the CRASH-2 randomised controlled trial | Q39401875 | ||
| Clinical pharmacology of tranexamic acid. | Q39688371 | ||
| High-dose tranexamic acid is an independent predictor of early seizure after cardiopulmonary bypass | Q39690108 | ||
| Trending Fibrinolytic Dysregulation: Fibrinolysis Shutdown in the Days After Injury Is Associated With Poor Outcome in Severely Injured Children | Q40145585 | ||
| Abnormalities in fibrinolysis at the time of admission are associated with deep vein thrombosis, mortality, and disability in a pediatric trauma population | Q40517099 | ||
| Sympathoadrenal activation and endotheliopathy are drivers of hypocoagulability and hyperfibrinolysis in trauma: A prospective observational study of 404 severely injured patients | Q40517107 | ||
| An evaluation of the euglobulin method for the determination of fibrinolysis | Q41285069 | ||
| Tranexamic acid use in severely injured civilian patients and the effects on outcomes: a prospective cohort study | Q41654746 | ||
| Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2) A randomised, placebo-controlled trial. | Q42731670 | ||
| Successful rotational thromboelastometry-guided treatment of traumatic haemorrhage, hyperfibrinolysis and coagulopathy | Q43254027 | ||
| Treatment of severe acute respiratory distress syndrome: a final report on a phase I study | Q43493864 | ||
| Prevalence and impact of abnormal ROTEM(R) assays in severe blunt trauma: results of the 'Diagnosis and Treatment of Trauma-Induced Coagulopathy (DIA-TRE-TIC) study'. | Q43867973 | ||
| Primary fibrinolysis is integral in the pathogenesis of the acute coagulopathy of trauma | Q44405049 | ||
| The incidence and magnitude of fibrinolytic activation in trauma patients | Q44658013 | ||
| Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study. | Q45103688 | ||
| Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations. | Q45880473 | ||
| Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway? | Q46166562 | ||
| Hyperfibrinolysis elicited via thromboelastography predicts mortality in trauma | Q46393514 | ||
| A new euglobulin clot lysis assay for global fibrinolysis | Q47891385 | ||
| Perioperative treatment algorithm for bleeding burn patients reduces allogeneic blood product requirements | Q48153196 | ||
| Correction of Severe Coagulopathy and Hyperfibrinolysis by Tranexamic Acid and Recombinant Factor VIIa in a Cirrhotic Patient After Trauma: A Case Report | Q48604141 | ||
| Tissue injury suppresses fibrinolysis after hemorrhagic shock in nonhuman primates (rhesus macaque). | Q49200827 | ||
| The impact of fresh frozen plasma vs coagulation factor concentrates on morbidity and mortality in trauma-associated haemorrhage and massive transfusion. | Q50543001 | ||
| [Tranexamic acid in the German emergency medical service : A national survey]. | Q52841804 | ||
| Detection of tPA-Induced Hyperfibrinolysis in Whole Blood by RapidTEG, KaolinTEG, and Functional FibrinogenTEG in Healthy Individuals | Q61783739 | ||
| Hyperfibrinolysis at admission is an uncommon but highly lethal event associated with shock and prehospital fluid administration | Q64039987 | ||
| The profibrinolytic effect of activated protein C in clots formed from plasma is TAFI-dependent | Q71571064 | ||
| Acute traumatic coagulopathy | Q73544166 | ||
| Vitronectin functions as a cofactor for rapid inhibition of activated protein C by plasminogen activator inhibitor-1. Implications for the mechanism of profibrinolytic action of activated protein C | Q73662364 | ||
| Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients | Q81163144 | ||
| Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis | Q81248493 | ||
| Multi-centre investigation on reference ranges for ROTEM thromboelastometry | Q81713778 | ||
| Hyperfibrinolysis after major trauma: differential diagnosis of lysis patterns and prognostic value of thrombelastometry | Q84203363 | ||
| Platelet function following trauma. A multiple electrode aggregometry study | Q84309499 | ||
| Normal range values for thromboelastography in healthy adult volunteers | Q84829142 | ||
| Hyperfibrinolysis diagnosed by rotational thromboelastometry (ROTEM) is associated with higher mortality in patients with severe trauma | Q84944599 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 35-44 | |
| P577 | publication date | 2017-09-16 | |
| P1433 | published in | European Journal of Trauma and Emergency Surgery | Q15755727 |
| P1476 | title | Fibrinolysis in trauma: a review | |
| P478 | volume | 44 |
| Q92459385 | A Machine Learning-Based Model to Predict Acute Traumatic Coagulopathy in Trauma Patients Upon Emergency Hospitalization |
| Q91867001 | Bad blood: A coagulopathy associated with trauma and massive transfusion review |
| Q64935415 | Modelling the association between fibrinogen concentration on admission and mortality in patients with massive transfusion after severe trauma: an analysis of a large regional database. |
| Q99636812 | TXA Administration in the Field Does Not Affect Admission TEG after Traumatic Brain Injury |
Search more.